Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy.
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis; D003524:Cyclosporins / Q000008:administration & dosage*; D003922:Diabetes Mellitus, Type 1 / Q000628:therapy; D004357:Drug Synergism; D006085:Graft Survival / Q000187:drug effects; D006087:Graft vs Host Reaction; D016027:Heart Transplantation; D007165:Immunosuppression Therapy; D007421:Intestine, Small / Q000637:transplantation; D016381:Islets of Langerhans Transplantation; D016030:Kidney Transplantation; D011971:Receptors, Immunologic / Q000276:immunology*; D015375:Receptors, Interleukin-2; D016038:Skin Transplantation; D013601:T-Lymphocytes / Q000145:classification
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D003524:Cyclosporins; D011971:Receptors, Immunologic; D015375:Receptors, Interleukin-2